Given our strategic location in the heart of Maryland’s vibrant biotech landscape, and our unique access to speciality items such as Paclitaxel and other oncolytics and injectables, Blue Door Pharma has become the “go to” distributor for many procurement officers.
Blue Door Pharma’s current customers are primarily US-based biotech companies with a general focus on pharmaceutical and biopharmaceutical research and development, and include some of the leaders in the industry, all who appreciate the value, quality, and service we provide.
Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. It is isolated from the bark of the Pacific Yew tree and named it taxol. Later it was discovered that a fungus in the bark synthesized the compound. In the commercial formulation of the drug, paclitaxel is dissolved in Cremophor EL and ethanol, as a delivery agent. A newer formulation, in which paclitaxel is bound to albumin, is sold under the trademark Abraxane (which Blue Door Pharma also supplies).
Paclitaxel is used to treat patients with lung, ovarian, breast, head and neck cancer, and advanced forms of Kaposi’s sarcoma. It is also used for the prevention of restenosis.
The product comes packaged as a single use vial containing 100 mg of paclitaxel.